Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Michael Burry who wrote (6867)	4/21/1999 3:06:00 PM
From: Wallace Rivers	Read Replies (1) \| Respond to of 78525

Mike; What do you think of SSI as an arb play (and I know we are a value investing thread!)? Current price of the proposed takeover is currently pegged at 9.50-10/share, plus you will receive a .285/share dividend (ex Apr. 28). Stock currently trading at about 9 3/8. Some feel the deal will be done at a higher price than currently proposed. Lowest NAV I've seen for SSI is $10.20, so maybe there is credence to this theory. Disclaimer: I own SSI.

To: Michael Burry who wrote (6867)	4/24/1999 6:28:00 PM
From: Allen Furlan	Read Replies (1) \| Respond to of 78525

Mike, being an MD you should have good insight on serologicals(sero). I bought a week ago a 5 1/16 and than added all week as I continued to sell covered calls. If stock retreats back to 6 or so I will probably add to my covered call positions. My reading of 10K shows this as solid value play at 6(now 7 1/2). Has anyone on thread read good analysis of the domino effect of momentum selloffs. SERO lost half of value(10 to 5) in one day. This was completely uncalled for and the stock recovered all of the next week. My speculation is that stop loss orders get triggered and the stock falls through all the stop loss levels at the onset of the fall and then nervous momentum players continue to sell to avoid margin calls. Sure would like to read something from an insiders perspective. This would be a good op-ed piece.